10393 San Diego Mission Rd, Suite 120
San Diego, CA 92108-2134
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
The lobulated, papillary, and vascular nature of the tumor can be seen. A gross total removal was accomplished. (Contributed by Dr. Sherman Stein.)
Nov. 07, 2020
Headache & Pain
May. 09, 2021
Hashimoto encephalopathy is a poorly understood syndrome of reversible cognitive impairment in the setting of antithyroid autoantibodies. There are no validated criteria for the diagnosis of the disease, but proposed diagnostic criteria include: (1) encephalopathy with seizures, myoclonus, or stroke-like episodes; (2) subclinical or mild overt thyroid disease; (3) normal or nonspecific abnormalities on brain MRI; (4) positive serum anti-TPO or anti-TG antibodies; (5) absence of well-characterized neuronal antibodies in CSF and serum; (6) reasonable exclusion of alternative causes.
Oct. 30, 2020
Neuro-Ophthalmology & Neuro-Otology
Oct. 21, 2020
Stroke & Vascular Disorders
Dec. 02, 2020
Clinical trials should fulfill standard criteria for methodological quality, assuring an objective estimate of treatment effects. The quality of clinical trials is now frequently evaluated according to the CONSORT statement. Currently, there are 14 FDA-approved disease-modifying therapies available for the treatment of relapsing-remitting multiple sclerosis.
Mar. 16, 2020
Pituitary adenomas represent 9% of intracranial neoplasms. Typical presenting manifestations include amenorrhea, infertility, visual field abnormalities, and headache. Diagnosis is often made with brain MRI, visual field testing, and serum hormone assay.
Jan. 28, 2021
May. 24, 2021